Filter
1039
Filtered Results: 1039
Text search:
Bolivia
Featured
Recommendations
52
New Publications
256
Language
Document type
No document type
510
Studies & Reports
267
Guidelines
118
Strategic & Response Plan
43
Manuals
34
Situation Updates
21
Fact sheets
16
Resource Platforms
12
Training Material
6
Brochures
6
Infographics
6
Countries / Regions
Latin America and the Carribbean
159
Venezuela
128
Bolivia
76
Global
76
Colombia
42
Argentina
25
Brazil
23
Peru
22
Ecuador
22
Paraguay
22
Chile
12
Haiti
10
Western and Central Europe
8
Uruguay
7
North America
6
Liberia
5
Kenya
5
Mozambique
5
Honduras
5
El Salvador
5
Mexico
5
Nicaragua
5
Guinea
4
Burkina Faso
4
Sierra Leone
4
Nigeria
4
Uganda
4
Dominican Republic
4
Cuba
4
Guatemala
4
Eastern Europe
4
Spain
4
Congo, Democratic Republic of
3
Ethiopia
3
Zimbabwe
3
India
3
Somalia
3
Nepal
3
Afghanistan
3
Zambia
3
Syria
3
Cambodia
3
Thailand
3
Indonesia
3
Bangladesh
3
South–East Asia Region
3
Senegal
2
Mali
2
Guinea-Bissau
2
USA
2
Ghana
2
Philippines
2
South Sudan
2
Iraq
2
Jordan
2
Germany
2
Tanzania
2
China
2
Madagascar
2
Yemen
2
West and Central Africa
2
Asia
2
Côte d’Ivoire / Ivory Coast
1
Niger
1
Togo
1
Pakistan
1
Egypt
1
Chad
1
Rwanda
1
South Africa
1
Malawi
1
Papua New Guinea
1
Benin
1
Central African Republic
1
Vanuatu
1
Angola
1
Sri Lanka
1
East and Southern Africa
1
Middle East and North Africa
1
Western Pacific Region
1
Africa
1
Solomon Islands
1
Palestine
1
North Korea
1
Timor Leste/ East Timor
1
Russia
1
Iran
1
Jamaica
1
French Guyana
1
Authors & Publishers
Publication Years
Category
Countries
385
Clinical Guidelines
84
Women & Child Health
59
Public Health
58
Key Resources
49
Capacity Building
12
Pharmacy & Technologies
10
Annual Report MEDBOX
1
Toolboxes
COVID-19
113
Mental Health
84
TB
75
HIV
59
NTDs
56
Planetary Health
53
Rapid Response
46
Zika
35
Disability
34
Global Health Education
33
Health Financing Toolbox
17
Refugee
16
AMR
15
Natural Hazards
14
Pharmacy
14
Conflict
12
Caregiver
11
NCDs
11
Ebola
7
Specific Hazards
6
Social Ethics
6
Polio
4
Cholera
2
Health Financing
1
El informe de este año presenta una actualización de la situación de la seguridad alimentaria y la nutrición en América Latina y el Caribe, incluyendo también estimaciones actualizadas sobre el costo y la asequibilidad de una dieta saludable (Parte 1). Además, el informe examina el complejo e...
April 2022 Volume 35 Issue 2 e00152-21
Population movements have turned Chagas disease (CD) into a global public health problem. Despite the successful implementation of subregional initiatives to control vectorial and transfusional Trypanosoma cruzi transmission in Latin American settings where t...
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
BMJ Glob Health 2017;2:e000345. doi:10.1136/bmjgh-2017-000345. WHO's 2020 milestones for Chagas disease include having all endemic Latin American countries certified with no intradomiciliary Trypanosoma cruzi transmission, and infected patients under care. Evaluating the variation in historical expo...
Trypanosoma cruzi is the etiological agent of Chagas disease (CD), considered one of the most important parasitic infections in Latin America. Between 25 and 90 million humans are at infection risk via at least one of multiple infection mechanisms. Under natural conditions, the principal transmissio...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
This report provides a review and analysis of the research landscape for three diseases – Chagas disease, human African trypanosomiasis and leishmaniasis – that disproportionately afflict poor and remote populations with limited access to health services. It represents the work of the disease re...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Two adjectives raise an issue for communicators working on Chagas disease (CD): “invisible and silent”. Two adjectives that can be ascribed to other neglected tropical diseases (NTD), but which are part of the essence of CD. Bringing CD out of its situation of neglect and oblivion is a mission e...
Localized cutaneous leishmaniasis and its evolving forms (diffuse cutaneous leishmaniasis, mucosal leishmaniasis and cutaneous leishmaniasis recidivans), together with the sequela of visceral leishmaniasis (post-kala-azar dermal leishmaniasis), account for about one million cases of dermal leishmani...
Leishmaniasis is a climate-sensitive disease. Changes in temperature, rainfall, and humidity can have strong impacts on
the sandfly vector, altering their distribution and influencing their survival and population sizes. Increased temperatures shorten vector development time, reduce Leishmania para...
La leishmaniasis es una enfermedad tropical desatendida sensible
al clima, trasmitida por la picadura de insectos flebótomos y
se calcula que amenaza a mil millones de personas en todo el mundo.
Esta enfermedad altamente compleja se presenta de varias formas
clínicas, causadas por 20 especies ...
PLoS Negl Trop Dis 15(8): e0009697. Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses t...
Research and Reports in Tropical Medicine 2022:13 25–40.
Chagas disease (CD) is caused by the parasite Trypanosoma cruzi, and it is endemic in Central, South America, Mexico and the South of the United States. It is an important cause of early mortality and morbidity, and it is associated with po...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Taenia saginata is a zoonotic tapeworm that is of economic importance in countries where cattle are kept. The parasite is transmitted from human tapeworm carriers (taeniosis) to bovines (cysticercosis) by excretion of eggs or proglottids containing eggs into the environment via the stool. Bovines ca...
PLoS Negl Trop Dis 16(10): e0009774. Although the practice of communication is often called upon when intervening asn involgvingcommunties affected by NTD's, the disciplinary framewokr of healt communication research has been largely absent from NTD strategies. To illustrate how practices conceptual...
Integrating the prevention and control of noncommunicable diseases in HIV/AIDS, tuberculosis, and sexual and reproductive health programmes: implementation guidance
The chapter Closing the Gap: The Health Disparities of Older LGBTI People in the Americas, is part of the publication series titled ‘Decade of Healthy Aging: situation and challenges’. In order to outline the current knowledge available on the situation of health and well-being of older persons ...
The chapter Closing the Gap: The Health Disparities of Older LGBTI People in the Americas, is part of the publication series titled ‘Decade of Healthy Aging: situation and challenges’. In order to outline the current knowledge available on the situation of health and well-being of older persons ...
